*AI trained on materials from the Brazilian Diabetes Society and under constant medical supervision regarding the information provided.

Try it on WhatsApp

The AI that supports more than 50,000 people with diabetes in Brazil via WhatsApp.

Talk to our team

Español

Carbohydrate Counting
Send text, voice, or a photo of your meal.

Insulin Dose Calculation
Based on individualized user parameters.

Glucose Tracking
Monitor time-in-range and average glucose.

Diabetes Education
Ask your questions and receive structured, evidence-based answers.

Reminders
Medication and meal reminders directly via WhatsApp.

Market intelligence consolidating Real World Evidence (RWE) data for public and private sector interventions.

AI Assistant integrated into the patient’s daily routine, reducing friction and increasing engagement.

Continuous education and training for patients and healthcare professionals within the public health system — the largest in the world.

WHAT WE DO

Patient Support Programs (PSPs)

Awareness campaigns

Public Policy Planning

Ad Segmentation

Premium Product Subscription

Care Pathways and Engagement Protocols

Market Intelligence on Behavior and Adherence

USERS

Patient Support Programs (PSPs)
Awareness campaigns
Public Policy Planning
Ad Segmentation
Premium Product Subscription
Care Pathways and Engagement Protocols
Market Intelligence on Behavior and Adherence

TODAY

+ 50,000 TOTAL USERS

+ 5.5 million messages handled

+ 35.000 Instagram followers

USERS DATA

Did your diabetes improve?
YES 85,7%

DIABETES
IN BRAZIL

• 10% of the population lives with diabetes — more than 20 million people (Vigitel 2023)

• US$ 41 billion is the annual cost of diabetes in Brazil (IDF)

• Approximately one-third of people living with diabetes remain undiagnosed in the country

MARKET
EXPANSION

Prevalence above 30% among the elderly population in Brazil.

50 million people projected to be living with diabetes in South and Central America by 2050.

Rapid expansion of the therapies and medical device market in the country.

"Brazil is the second country that searches the most for Mounjaro and Ozempic worldwide"

Shall we shape the future of diabetes care in Brazil?

Leonardo Scandolara Jr, co-founder and COO
+55 34 99303-6774
leoscandolara@tiabeteoficial.com.br
www.linkedin.com/in/leonardo-scandolara-junior-081a221a3

Felipe Muller Oliveira, co-founder and CEO
+55 16 99717-0033
felipemuller@tiabeteoficial.com.br
https://www.linkedin.com/in/felipe-muller-oliveira/

Wilkor Ribeiro Almeida, CTO
+55 11 970950034
wilkor.almeida@gmail.com
https://www.linkedin.com/in/wilkor-ribeiro-almeida-0b8a17b9